2024 Annual Meeting | C108 - Sequelae of COVID-19

Date Tuesday 04/16/24

Time 07:00 AM - 09:00 AM MDT Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program will be available in the meeting's On Demand product.

Event Type Seminar

Director(s) Kenneth L. Tyler, MD, FAAN

Topic(s) Infectious Disease

Learning Objectives Participants should become familiar with the major neurologic manifestations of the post-acute sequelae of COVID-19 ("long COVID") including the symptomatology and role of diagnostic testing. Participants will be updated on the latest concepts for pathogenesis of long COVID's neurological symptoms. An updated review of the treatment and management of symptoms will be presented based on latest available evidence and parallel applications in other settings.

CME Available 2.00 CME credits

Core Competencies Patient Care & Procedural Skills, Medical Knowledge

Program Level Intermediate

Program Tracks Brain Health

Recommended Audience Fellow, Resident, General Neurologist, Specialist Neurologist, Advanced Practice Provider, Neurohospitalist, Medical Student

Teaching Styles Didactic

Program Evaluations

Event Timeline
07:00 AM - 07:15 AM MDT	Speaker	Patient Presentation: Neurological Sequelae of Long COVID Igor J. Koralnik, MD, FAAN
07:15 AM - 07:45 AM MDT	Speaker	Neurological Manifestations of Long COVID Igor J. Koralnik, MD, FAAN
07:45 AM - 08:15 AM MDT	Speaker	Neuropathogenesis of COVID Avindra Nath, MD, MBBS, FAAN
08:15 AM - 08:45 AM MDT	Speaker	Management Strategies for Neurological Long COVID Jennifer A. Frontera, MD
08:45 AM - 09:00 AM MDT	Discussion	Discussion Kenneth L. Tyler, MD, FAAN, Igor J. Koralnik, MD, FAAN, Avindra Nath, MD, MBBS, FAAN, Jennifer A. Frontera, MD

Faculty Disclosures
Avindra Nath, MD, MBBS, FAAN	The institution of Dr. Nath has received research support from National Institutes of Health. The institution of Dr. Nath has received research support from Target ALS. Dr. Nath has received intellectual property interests from a discovery or technology relating to health care.
Kenneth L. Tyler, MD, FAAN	Dr. Tyler has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Protagonist Therapeutics, Newark CA. Dr. Tyler has received personal compensation in the range of $50,000-$99,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Neurological Association/Wiley. Dr. Tyler has received intellectual property interests from a discovery or technology relating to health care. Dr. Tyler has received publishing royalties from a publication relating to health care. Dr. Tyler has a non-compensated relationship as a Director (ex officio) with American Neurological association that is relevant to AAN interests or activities. Dr. Tyler has a non-compensated relationship as a Director with International Society for Neurovirology that is relevant to AAN interests or activities.
Igor J. Koralnik, MD, FAAN	Dr. Koralnik has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Journal of Clinical Investigation. The institution of Dr. Koralnik has received research support from National Institutes of Health. Dr. Koralnik has received publishing royalties from a publication relating to health care.
Jennifer A. Frontera, MD	Dr. Frontera has received personal compensation in the range of $500-$4,999 for serving as a Consultant for FirstKindMedical. Dr. Frontera has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Physician ��ɫ�� Resource. The institution of Dr. Frontera has received research support from NIH. The institution of Dr. Frontera has received research support from Alexion. Dr. Frontera has received publishing royalties from a publication relating to health care.

��ɫ����

��ɫ����

��ɫ��

��ɫ��